The SCRI
The SCRI was founded in 2013.
Research at the Laboratory for Immunological and Molecular Cancer Research (LIMCR) and the Center for Clinical Cancer and Immunology Trials (CCCIT) at the Department of Medicine III pursues the closest possible link between basic science and clinical research for the benefit of patients.
Maximum quality in the care of all tumor diseases at the III. Medicine, clinical research, which can make the latest possible therapy concepts and drugs available to patients years before approval, and immunological and molecular cancer research are brought to maximum synergy.
Creating synergies to maximize the benefit of all efforts for the patient’s interest
Cancer research in Austria
5 %
in survival rates worldwide
55 %
Survival rate for men
58 %
Survival rate for women
100 %
Dedication to cancer research
Do you have a request or questions?
Get in touch with us – we will get back to you as soon as possible.
